long term safety of glp-1 Long-Term Safety: GI Risks After 3 Years GLP-1 Agonists: Using Semaglutide, Tirzepatide,

2004;53(suppl 3):S48-S58

Although uncommon, liraglutide has been shown to cause mild pancreatitis, with elevated serum amylase or lipase levels

Amgen GlaxoSmithKline Bristol-Myers Squibb Takeda Pharmaceutical Company Daiichi Sankyo Pfizer Teva Pharmaceutical Industries Regeneron Pharmaceuticals Intarcia Therapeutics Hngzhou Jiuyuan Gene Engineering Co Ltd

Zepbound is approved for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related health condition and should be used alongside a reduced-calorie diet and increased physical activity

The advancements in GLP-1 treatments represent a significant breakthrough in medical weight management